Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Probiotic pill could shield city workers from air pollution harm

NCT ID NCT07418489

First seen Feb 23, 2026 · Last updated Jun 23, 2026 · Updated 22 times

Summary

This study tests whether a daily probiotic supplement can reduce inflammation and other early signs of harm caused by air pollution. Seventy street market vendors in Turin, Italy, will take either the probiotic or a placebo for four months. Researchers will measure changes in blood markers, DNA damage, and gut bacteria to see if the supplement offers protection.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEALTHY 70 STREET MARKET VENDORS WORKING IN HIGHLY-POLLUTED AREAS OF TURIN are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • University of Turin - Department of Public Health and Pediatrics

    Turin, 10126, Italy

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

probiotic blend (live and heat-inactivated bacteria)

What this could lead to

If it works, this could point toward a simple dietary supplement to help protect people from some of the harmful effects of air pollution.

What could go wrong

This is a small, early-stage trial in healthy people, so results may not apply to everyone. The supplement may not reduce inflammation or DNA damage as hoped.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.